Loading the company…
Loading the company…
Families: Cervical fusion & disc arthroplasty, Lumbar fusion.
All companies · Product and company coverage
In the last ten years FDA made 26 decisions for Centinel Spine (510(k) clearances, De Novo grants, PMA approvals and supplements) under the product codes MedaRep maps to 2 procedure families, the most in 2025 (7). The latest was on 2026-09-09.
| Family | Decisions on record |
|---|---|
| Cervical fusion & disc arthroplasty | 59 |
| Lumbar fusion | 6 |
| Date | Kind | Number | Device |
|---|---|---|---|
| 2026-09-09 | PMA | P070001-S031 | prodisc® C Nova · Labeling Change - Indications/instructions/shelf life/tradename |
| 2026-01-15 | PMA | P070001-S030 | prodisc® C · Process Change - Manufacturer/Sterilizer/Packager/Supplier |
| 2025-10-10 | PMA | P070001-S025 | prodisc C SK and prodisc C Vivo · Labeling Change - Indications/instructions/shelf life/tradename |
| 2025-09-02 | PMA | P050010-S027 | PRODISC L · Location Change - Manufacturer/Sterilizer/Packager/Supplier |
In 2025, Centinel Spine reported engagement with 435 surgeons and other clinicians in the states MedaRep covers, worth $866K in consulting, speaking, meals and travel for its device products, the most in Texas ($356K to 53). Royalties are left out.
Spend tied to a procedure counts the payments whose product names it. Open Payments shows the payments companies reported. It suggests engagement, not which devices a surgeon uses, and is not evidence of wrongdoing.Top states by spend: Texas ($356K, 53 engaged), Arizona ($150K, 21 engaged), California ($131K, 88 engaged), Florida ($30K, 32 engaged), Colorado ($27K, 27 engaged).
| 2025-07-30 | PMA | P070001-S029 | prodisc® C · Process Change - Manufacturer/Sterilizer/Packager/Supplier |
Decisions under the product codes mapped to the procedure families; devices filed under other codes are not here. Applicants are rolled up to Centinel Spine.